home / stock / nrix / nrix quote
Last: | $16.59 |
---|---|
Change Percent: | 0.06% |
Open: | $15.39 |
Close: | $16.59 |
High: | $16.84 |
Low: | $14.5286 |
Volume: | 3,038,632 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$16.59 | $15.39 | $16.59 | $16.84 | $14.5286 | 3,038,632 | 05-17-2024 |
$15.4 | $15.87 | $15.4 | $15.94 | $15.055 | 584,716 | 05-16-2024 |
$15.9 | $15.41 | $15.9 | $16.57 | $15.41 | 979,076 | 05-15-2024 |
$14.95 | $14.55 | $14.95 | $15.21 | $14.5 | 1,488,963 | 05-14-2024 |
$13.94 | $13.69 | $13.94 | $13.98 | $13.55 | 326,778 | 05-13-2024 |
$13.51 | $14.05 | $13.51 | $14.05 | $13.23 | 335,009 | 05-10-2024 |
$13.95 | $14.06 | $13.95 | $14.52 | $13.79 | 612,560 | 05-09-2024 |
$13.98 | $13.86 | $13.98 | $14.31 | $13.56 | 476,636 | 05-08-2024 |
$14.16 | $13.29 | $14.16 | $14.37 | $13.18 | 644,614 | 05-07-2024 |
$13.22 | $12.81 | $13.22 | $13.51 | $12.77 | 436,580 | 05-06-2024 |
$12.78 | $13.15 | $12.78 | $13.73 | $12.7 | 465,539 | 05-03-2024 |
$12.73 | $13.4 | $12.73 | $13.4 | $12.61 | 1,200,167 | 05-02-2024 |
$13.08 | $12.08 | $13.08 | $13.6 | $12.04 | 810,852 | 05-01-2024 |
$12.02 | $12.25 | $12.02 | $12.5 | $11.9 | 1,505,032 | 04-30-2024 |
$12.47 | $12.57 | $12.47 | $12.98 | $12.37 | 1,131,916 | 04-29-2024 |
$12.36 | $12.49 | $12.36 | $12.61 | $12.17 | 599,965 | 04-26-2024 |
$12.36 | $13.29 | $12.36 | $13.3363 | $12.2701 | 966,502 | 04-25-2024 |
$13.75 | $14.05 | $13.75 | $14.42 | $13.52 | 519,760 | 04-24-2024 |
$14.13 | $13.59 | $14.13 | $14.44 | $13.59 | 687,984 | 04-23-2024 |
$13.58 | $13.69 | $13.58 | $14.1 | $13.3 | 574,496 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Nurix Therapeutics Inc. Company Name:
NRIX Stock Symbol:
NASDAQ Market:
Overall response rate of 70% observed in 10 evaluable heavily pretreated CLL patients Data showcase deepening clinical responses with longer time ...
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (NASDAQ:NRIX), a clinical-stage biopharmaceutical company developing ta...
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Net revenue (managed) ...